Comparative Pharmacology
Head-to-head clinical analysis: AQUASOL A versus VITAMIN A SOLUBILIZED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AQUASOL A versus VITAMIN A SOLUBILIZED.
AQUASOL A vs VITAMIN A SOLUBILIZED
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Vitamin A is essential for vision, epithelial differentiation, bone growth, reproduction, and immune function. It acts as a retinol-binding protein that regulates gene expression through retinoic acid receptors.
Vitamin A (retinol) is essential for vision, immune function, and cellular differentiation. It binds to nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), regulating gene transcription. In the retina, it forms rhodopsin, a light-sensitive pigment necessary for low-light vision.
100,000 to 200,000 IU intramuscularly once monthly for prophylaxis; 50,000 to 100,000 IU intramuscularly daily for 3 days for severe deficiency.
Vitamin A solubilized: 10,000-50,000 IU orally once daily for deficiency. For severe deficiency: 100,000 IU intramuscularly once, repeated in 24 hours if needed. Maintenance: 10,000-20,000 IU orally daily.
None Documented
None Documented
Terminal elimination half-life: 24-48 hours (mean 36 h); prolonged in renal impairment; clinical context: steady-state achieved in ~5-7 days with daily dosing.
Terminal half-life: 12.5–60 days (mean ~25 days) in adults; prolonged in hypervitaminosis A. Clinical context: Accumulation risk with chronic use due to slow elimination.
Renal: ~60% as metabolites; fecal: ~30% as unchanged drug and metabolites; biliary: ~10%.
Renal: <1% as unchanged drug; biliary/fecal: >90% as metabolites and conjugated forms.
Category C
Category C
Vitamin A
Vitamin A